Moderna stock rises after Phase 3 melanoma data showcased at Presidential Symposium; peers Merck and BioNTech also advance
Moderna surges 9% as Phase 3 melanoma data wins Presidential Symposium slot.
economy5 h ago
Yahoo FinanceRead original ↗
About
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Source: Wikipedia (CC BY-SA)On coda.news
1 event, reported by media in 1 country
